Case Report
Toxic Epidermal Necrolysis as a Complication of Treatment with Voriconazole
Abstract
An 81-year-old female received voriconazole in a 7-day treatment course for a symptomaticCandida krusei urinary tract infection. Four days after the last dose, she developed toxic epidermal necrolysis. She was treated with intravenous immunoglobulin, and her symptoms promptly resolved.
Key Points
* The most common mucosal membranes involved in toxic epidermal necrolysis (TEN) are, in order of decreasing frequency, the oropharynx, eyes, genitalia, and anus.
* Voriconazole is not known to be a medication commonly associated with TEN.
* The most commonly reported voriconazole-related adverse events include elevation in hepatic transaminases or bilirubin, skin rash, abnormal vision, and a photosensitivity reaction.
* TEN should be strongly considered in individuals receiving voriconazole with temporally related characteristic lesions of the skin and mucous membranes, since this disorder can cause considerable morbidity and mortality.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.